Morning Overview on MSN
UC San Diego’s experimental pill just reversed the worst form of fatty liver disease in trial patients — shutting off the single enzyme driving fat buildup and inflammation
A single enzyme inside liver cells drives the production of triglycerides that, in excess, fuel the inflammation and scarring ...
Eating too much added sugar may increase liver fat and raise the risk of fatty liver disease. Talk to your healthcare provider about appropriate diet changes.
A medication long used to help people breathe may soon help protect the liver as well. Researchers at the Medical University ...
MENLO PARK, Calif., February 10, 2026--(BUSINESS WIRE)--OrsoBio, a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, today announced positive ...
November 9, 2010 (Boston, Massachusetts) — A 4.3% reduction in body weight and an approximate 42% reduction of triglyceride levels in subjects with nonalcoholic fatty liver disease (NAFLD) was ...
Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase ...
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease ...
Resistant starch is a nondigestible fiber that ferments in the large intestine, and consumption of it has previously been shown to have a positive effect on metabolism in animal studies. Now, a ...
Kolkata: In a paper published in the international journal Nature Communications, a team of scientists from the Saha Institute of Nuclear Physics, Kolkata, that operates under the department of atomic ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that new 48-week data from the IMPACT Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results